Not applicableAvailableNCT03773770What this trial is testingExpanded Access to TriheptanoinWho this might be right forLong Chain Fatty Acid Oxidation Disorders Ultragenyx Pharmaceutical Inc
Not applicableStudy completedNCT00328159What this trial is testingNutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty AcidsWho this might be right forInborn Errors of Metabolism Assistance Publique - Hôpitaux de Paris 20
Testing effectiveness (Phase 2)Study completedNCT01886378What this trial is testingUX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)Who this might be right forLong-chain Fatty Acid Oxidation Disorders (LC-FAOD)Carnitine Palmitoyltransferase (CPT II) DeficiencyVery Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency+2 more Ultragenyx Pharmaceutical Inc 29
Not applicableStudy completedNCT05687474What this trial is testingBaby Detect : Genomic Newborn ScreeningWho this might be right forCongenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT02214160What this trial is testingLong-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin StudiesWho this might be right forCarnitine Palmitoyltransferase (CPT I or CPT II) DeficiencyVery Long Chain Acyl-CoA Dehydrogenase (VLCAD) DeficiencyLong-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency+2 more Ultragenyx Pharmaceutical Inc 94